ESMO – European Society for Medical Oncology shared a post on LinkedIn:
” New ESMO Clinical Practice Guideline recommendations in Advanced Colorectal Cancer: fruquitinib in chemorefractory patients and the use of KRAS G12C inhibitors.”
More posts featuring European Society for Medical Oncology.